[349 Pages Report] The global demand for breast lesion localization devices market is set to grow by 5.5% from 2022 to 2032, with an estimated market value of around US$ 325.5 Million as of 2022. The breast biopsy segment accounted for the leading share of about 61.3% of the breast lesion localization devices market based on application in 2021.
Market Outlook:
| Data Points | Market Insights |
|---|---|
| Breast Lesion Localization Devices Market Value 2021 | US$ 309.6 Million |
| Market Value 2022 | US$ 325.5 Million |
| Market Value 2032 | US$ 554.9 Million |
| CAGR 2022 to 2032 | 5.5% |
| Market Share of Top 5 Countries | 52.4% |
Lifestyle changes, which include behavioral factors, dietary preference, and physical activity, can worsen breast cancer. Women who are overweight have greater insulin levels in their blood. Some malignancies, especially breast cancer, have been associated with higher levels of insulin.
Drinking alcohol, obesity, use of birth control, menopausal hormone treatment, and breast implants are all lifestyle factors that can lead to breast cancer.
According to statistics presented by the American Cancer Society in 2020; alcohol intake proportionally increases the risk of breast cancer. Women who have one alcoholic drink per day have a minor (7-10%) increase in risk compared to those who do not, whereas those who have two to three drinks per day face a 20 percent increase in risk.
An advanced localization approach could make breast surgeries more precise, simpler, and more convenient for radiologists and surgeons. This is creating huge opportunities for players to come into this market and acquire market space with new technologies.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global market for breast lesion localization devices expanded at a CAGR of 4.7% over the last five years (2017 to 2021), as per Future Market Insights (FMI). The market value for breast lesion localization devices holds nearly 7.7% of the overall ~US$ 4 Billion breast cancer diagnostic market in 2021.
The growing prevalence of breast cancer will drive the demand for breast lesion localization devices in the near future. Breast cancer may spread to other areas of the body most common first detectable site of the spread is the lymph nodes under the arms, there is some lesion in lymph nodes that cannot be felt by touching.
Survival of breast cancer for at least 5 years after diagnosis is 40% in South Africa, 66% in India, and 90% in high-income countries. Early detection and treatment have proven successful in high-income countries in decreasing the risk associated with breast cancer.
Early cancer detection necessitates the use of suitable screening methods to examine the asymptomatic population, which has an average cancer risk, particularly for breast cancer. Increased understanding of cancer's early signs and symptoms among physicians and other healthcare professionals, as well as the general public, is very important. Improvements in healthcare policies in developing countries will boost market growth.
Players in the breast lesion diagnostic market are focusing on collaborating with hospitals and ambulatory surgical centers for direct sales and maintenance of the equipment along with training personnel to increase awareness about new technology.
An increase in the funding for cancer research has driven many cancer research institutes and has led to substantial improvements in patient survival rates and dramatic improvements in the quality of life for patients with cancer.
For Instance, The Consolidated Appropriations Act of 2022 allocated US$6.9 billion to NCI, a US$353 million net increase over FY 2021.
The market is expected to expand at a significant rate over the next ten years at a CAGR growth value close to 5.5% and offers an absolute $ opportunity of US$ 17.2 Million.
The above-mentioned factors are primarily insightful concerning the global sales growth of the breast lesion localization devices market and are anticipated to persistently progress market growth over the forecasted period of 2022 to 2032.
Breast lesion localization devices are increasingly used in the detection and mapping of breast cancer. However, only a few players are actively engaged in the manufacturing of breast lesion localization devices to date, implying that there are significant opportunities for other small and large manufacturers to enter the market, as demand for the devices is rapidly increasing.
Breast cancer is the most common cancer in emerging nations and its incidence is surging rapidly among women in metropolitan regions. The importance of early detection in the management and treatment of this condition cannot be overstated. As a result, breast cancer awareness activities are organized to raise awareness and eliminate the stigma associated with breast cancer symptoms and treatment.
For instance, the International Federation of Medical Students' Associations has launched Breast Cancer Awareness Programmes (BCAP) to raise awareness among men and women about cancers of sexual organs.
The presence of a larger patient pool with cancer, along with increasing per capita income will provide lucrative opportunities for market penetration and growth within worldwide economies.
Principal Consultant
Factors restraining the demand for breast lesion localization devices include the high cost of devices and a dearth of trained professionals who can carry out critical and advanced processes for the detection of lesions.
Breast cancer surgeries such as breast lumpectomy, breast biopsy, and other procedures are high-cost operations. Due to the high cost of the devices, the cost of their high services, and devices inaccessible for most patients in most countries which is a major restraining factor for the market.
Breast lesion localization devices are the most advanced method of lesion detection. This method requires expertise on the part of the staff and trainees. Many hospitals and healthcare centers lack such skilled professionals to use these devices during diagnosis or surgeries. This is expected to hamper the adoption of these devices, which in turn restrain the market’s growth.
High Government Expenditure on Breast Cancer Research to Spur Growth
The USA leads North America with a market share of about 82.3% in 2021 and is estimated to show high growth throughout the forecast period. Improving government expenditures on breast cancer research, raising awareness of breast cancer early detection, easy FDA Approval, and increasing usage of devices in cancer centers in the USA is the major factor boosting the market growth in the region.
For instance, in May 2021, MOLLI Surgical Inc. got USA Food and Drug Administration clearance for MOLLI™, a new wire-free localization technology for breast cancer surgery.
High Awareness About Personal Health and Wellness Among People Supporting Sales in the UK
UK is set to exhibit a CAGR of nearly 5.9% in the European breast lesion localization devices market during the forecast period. The population in the UK is more aware of personal health and not only diagnosis but also the screening rate for cancer is high in this region, so the growth rate of the breast lesion localization devices market is seen to be at an upsurge in the region.
UK’s large geriatric population and older adults are more likely to suffer from breast cancer than younger people due to weak immune responses and changing lifestyles. These factors drive the breast lesion localization market.
Rising Burden of Breast Cancer Patients Makes China a Leading Market
China is the fastest growing with a CAGR of 6.7% in the East Asia market during the forecast period. The rising burden of breast cancer patients in the country reflects its stronghold upon the breast lesion localization devices market.
As per the estimates reported by Statistics 2020, Nearly 416 thousand new breast cancer cases were diagnosed among the Chinese female population in 2020.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Cost-effectiveness of Wire Localization Makes it Sought-After Technique
The wire localization segment held the dominant share of 41.9% in 2021, owing to its cost-effectiveness, and ease for surgeons and radiologists to use it while processing also wire localization devices have plenty of options that can easily be connected to radiology imaging devices with guided wire. These all factors are driving the demand for the breast localization devices market.
Application in Breast Biopsy to Spur Sales Prospects
Breast biopsy demand is estimated to grow at a CAGR of 4.9% throughout the forecast period of 2022 to 2032. The segment accounted for 61.3% of overall sales in the market in 2021. The metrics are valued as per the patient flow for the breast biopsy and increasing awareness for early diagnosis of a breast lesion with biopsy. This makes the biopsy segment grow with great market space.
Demand from Hospitals to Continue Supporting Growth
Hospitals as end users lead the breast lesion localization devices market with about 42.3% market share in 2021. Hospitals have a huge amount of footfall for diagnosis and surgeries of breast cancer also companies are focusing on unique strategies of training surgeons and radiologists in hospitals for more patient reach this is gaining traction.
Key players are focused on the development and launch of novel detection devices for breast cancers. Established players within the industry are targeting specific female groups and going after strategic mergers and acquisitions to strengthen their position in the cancer devices market.
Similarly, recent developments related to companies manufacturing breast lesion localization device techniques have been tracked by the team at Future Market Insights, which are available in the full report.
| Attribute | Details |
|---|---|
| Forecast Period | 2022 to 2032 |
| Historical Data Available for | 2017 to 2021 |
| Market Analysis | US$ Million for Value and Volume in Units |
| Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, Germany, UK, France, Italy, Spain, Russia, BENELUX, Nordic countries and Russia, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Australia, New Zealand, GCC Countries, Turkey, and South Africa |
| Key Market Segments Covered | Technique, Application, End User, and Region |
| Key Companies Profiled |
|
| Pricing | Available upon Request |
The global Breast lesion localization devices market is worth US$ 309.6 Million at present (2021) and is set to expand 1.7X over the next ten years.
The Breast lesion localization devices market is expected to reach US$ 554.9 Million by the end of 2032, with sales revenue expected to register a 5.5% CAGR.
The shift from invasive to minimally-invasive surgical procedures, acquisitions and collaborations by key players, growing approval for the devices and the addition of innovative techniques in the portfolio through partnerships are some of the key trends being witnessed in this marketplace.
The USA, UK, India, Germany and Japan are expected to drive demand for breast lesion localization devices.
North America is one of the key markets for breast lesion localization devices, with the USA expected to account for over 82.3% of the North American market in 2021.
Demand for breast lesion localization devices in Europe is expected to register a growth of 5.7%over the next ten years.
The USA, UK and Germany are the key producers of breast lesion localization devices.
Merit Medical Systems, BD, ARGON MEDICAL, Hologic, Inc., Endomagnetics Ltd. are the key exporters of the breast lesion localization devices market.
1. Executive Summary | Breast Lesion Localization Device Market 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Key Success Factors 4.1. Product USPs 4.2. Recent product approval and launches 4.3. Key Promotional Strategies by Market Players 4.4. Product Adoption/ Usage Analysis by Region 4.5. Regulatory Scenario 4.6. Reimbursement Scenario 4.7. Disease Epidemiology 4.8. PESTEL Analysis 4.9. Portal Analysis 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Healthcare Expenditure 5.1.3. Aging Population 5.1.4. Infrastructure Investment 5.2. Forecast Factors - Relevance & Impact 5.2.1. Rising Cancer Awareness 5.2.2. Rising prevalence of Breast cancer 5.2.3. Growing Investment in healthcare expenditure 5.2.4. Product Innovation and Development 5.2.5. Cost Impact 5.2.6. Rising Demand in Emerging Economies 5.2.7. Strategic Mergers and Acquisitions Among Local 5.3. Value Chain 5.3.1. Raw Technique Suppliers 5.3.2. Product Manufacturers 5.3.3. End Users 5.4. Market Dynamics 5.4.1. Drivers 5.4.2. Restraints 5.4.3. Opportunity Analysis 6. COVID19 Crisis Analysis 6.1. Current COVID-19 Statistics and Probable Future Impact 6.2. Current GDP Projection and Probable Impact 6.3. COVID-19 and Impact Analysis 6.4. 2021 Market Scenario 6.5. Recovery Scenario - Short-term, Midterm, and Long-Term Impact 7. Global Market - Pricing Analysis 7.1. Regional Pricing Analysis By Technique 7.2. Global Average Pricing Analysis Benchmark 8. Global Market Demand (in Volume or Size in Unit) Analysis 2017 to 2021 and Forecast, 2022 to 2032 8.1. Historical Market Volume (Unit) Analysis, 2017 to 2021 8.2. Current and Future Market Volume (Unit) Projections, 2022 to 2032 8.2.1. Y-o-Y Growth Trend Analysis 9. Global Market Demand (in Value or Size in US$ Million) Analysis 2017 to 2021 and Forecast, 2022 to 2032 9.1. Historical Market Value (US$ Million) Analysis, 2017 to 2021 9.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2032 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Technique 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Million) Analysis By Technique, 2017 to 2021 10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Technique, 2022 to 2032 10.3.1.1. Wire Localization 10.3.1.2. Non-Wires Localization 10.3.1.3. Radar Reflector Localization 10.3.1.4. Magnetic Seed Localization 10.3.1.5. RFID Tag Localization 10.3.1.6. Radioisotope Localization 10.4. Market Attractiveness Analysis By Technique 11. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Application 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Million) Analysis, By Application, 2017 to 2021 11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2022 to 2032 11.3.1. Breast Biopsy 11.3.2. Breast Lumpectomy 11.4. Market Attractiveness Analysis By Application 12. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Million) Analysis, By End User, 2017 to 2021 12.3. Current and Future Market Size (US$ Million) Analysis Forecast By End User, 2022 to 2032 12.3.1. Specialty Clinics 12.3.2. Hospitals 12.3.3. Ambulatory Surgical Centers 12.4. Market Attractiveness Analysis By End User 13. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, by Region 13.1. Introduction 13.2. Historical Market Size (US$ Million) Analysis By Region, 2017 to 2021 13.3. Current Market Size (US$ Million) Analysis and Forecast By Region, 2022 to 2032 13.3.1. North America 13.3.2. Latin America 13.3.3. Europe 13.3.4. East Asia 13.3.5. South Asia 13.3.6. Oceania 13.3.7. Middle East and Africa (MEA) 13.4. Market Attractiveness Analysis By Region 14. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032 14.1. Introduction 14.2. Pricing Analysis 14.3. Historical Market Size (US$ Million) Analysis Trend Analysis By Market Taxonomy, 2017 to 2021 14.4. Market Size (US$ Million) Analysis Forecast By Market Taxonomy, 2022 to 2032 14.4.1. By Country 14.4.1.1. United States of America 14.4.1.2. Canada 14.4.2. By Technique 14.4.3. By Application 14.4.4. By End User 14.5. Market Attractiveness Analysis 14.5.1. By Country 14.5.2. By Technique 14.5.3. By Application 14.5.4. By End User 14.6. Market Trends 14.7. Key Market Participants - Intensity Mapping 14.8. Drivers and Restraints - Impact Analysis 14.9. Country-Level Analysis & Forecast 14.9.1. USA Market Analysis 14.9.1.1. .Introduction 14.9.1.2. Market Analysis and Forecast by Market Taxonomy 14.9.1.2.1. By Technique 14.9.1.2.2. By Application 14.9.1.2.3. By End User 14.9.2. Canada Market Analysis 14.9.2.1. Introduction 14.9.2.2. Market Analysis and Forecast by Market Taxonomy 14.9.2.2.1. By Technique 14.9.2.2.2. By Application 14.9.2.2.3. By End User 15. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032 15.1. Introduction 15.2. Pricing Analysis 15.3. Historical Market Size (US$ Million) Analysis Trend Analysis By Market Taxonomy, 2017 to 2021 15.4. Market Size (US$ Million) Analysis Forecast By Market Taxonomy, 2022 to 2032 15.4.1. By Country 15.4.1.1. Mexico 15.4.1.2. Brazil 15.4.1.3. Argentina 15.4.1.4. Rest of Latin America 15.4.2. By Technique 15.4.3. By Application 15.4.4. By End User 15.5. Market Attractiveness Analysis 15.5.1. By Country 15.5.2. By Technique 15.5.3. By Application 15.5.4. By End User 15.6. Market Trends 15.7. Key Market Participants - Intensity Mapping 15.8. Drivers and Restraints - Impact Analysis 15.9. Country-Level Analysis & Forecast 15.9.1. Mexico Market Analysis 15.9.1.1. Introduction 15.9.1.2. Market Analysis and Forecast by Market Taxonomy 15.9.1.2.1. By Technique 15.9.1.2.2. By Application 15.9.2. Brazil Market Analysis 15.9.2.1. Introduction 15.9.2.2. Market Analysis and Forecast by Market Taxonomy 15.9.2.2.1. By Technique 15.9.2.2.2. By Application 15.9.2.2.3. By End User 15.9.3. Argentina Market Analysis 15.9.3.1. Introduction 15.9.3.2. Market Analysis and Forecast by Market Taxonomy 15.9.3.2.1. By Technique 15.9.3.2.2. By Application 15.9.3.2.3. By End User 16. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032 16.1. Introduction 16.2. Pricing Analysis 16.3. Historical Market Size (US$ Million) Analysis Trend Analysis By Market Taxonomy, 2017 to 2021 16.4. Market Size (US$ Million) Analysis Forecast By Market Taxonomy, 2022 to 2032 16.4.1. By Country 16.4.1.1. Germany 16.4.1.2. Italy 16.4.1.3. France 16.4.1.4. United Kingdom 16.4.1.5. Spain 16.4.1.6. BENELUX 16.4.1.7. Nordic Countries & Russia 16.4.1.8. Rest of Europe 16.4.2. By Technique 16.4.3. By Application 16.4.4. By End User 16.5. Market Attractiveness Analysis 16.5.1. By Country 16.5.2. By Technique 16.5.3. By Material 16.5.4. By End User 16.6. Market Trends 16.7. Key Market Participants - Intensity Mapping 16.8. Drivers and Restraints - Impact Analysis 16.9. Country-Level Analysis & Forecast 16.9.1. Germany Market Analysis 16.9.1.1. Introduction 16.9.1.2. Market Analysis and Forecast by Market Taxonomy 16.9.1.2.1. By Technique 16.9.1.2.2. By Application 16.9.1.2.3. By End User 16.9.2. Italy Market Analysis 16.9.2.1. Introduction 16.9.2.2. Market Analysis and Forecast by Market Taxonomy 16.9.2.2.1. By Technique 16.9.2.2.2. By Application 16.9.2.2.3. By End User 16.9.3. France Market Analysis 16.9.3.1. Introduction 16.9.3.2. Market Analysis and Forecast by Market Taxonomy 16.9.3.2.1. By Technique 16.9.3.2.2. By Application 16.9.3.2.3. By End User 16.9.4. UK Market Analysis 16.9.4.1. Introduction 16.9.4.2. Market Analysis and Forecast by Market Taxonomy 16.9.4.2.1. By Technique 16.9.4.2.2. By Application 16.9.4.2.3. By End User 16.9.5. Spain Market Analysis 16.9.5.1. Introduction 16.9.5.2. Market Analysis and Forecast by Market Taxonomy 16.9.5.2.1. By Technique 16.9.5.2.2. By Application 16.9.5.2.3. By End User 16.9.6. BENELUX Market Analysis 16.9.6.1. Introduction 16.9.6.2. Market Analysis and Forecast by Market Taxonomy 16.9.6.2.1. By Technique 16.9.6.2.2. By Application 16.9.6.2.3. By End User 16.9.7. Nordic Countries & Russia Market Analysis 16.9.7.1. Introduction 16.9.7.2. Market Analysis and Forecast by Market Taxonomy 16.9.7.2.1. By Technique 16.9.7.2.2. By Application 16.9.7.2.3. By End User 17. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032 17.1. Introduction 17.2. Pricing Analysis 17.3. Historical Market Size (US$ Million) Analysis Trend Analysis By Market Taxonomy, 2017 to 2021 17.4. Market Size (US$ Million) Analysis Forecast By Market Taxonomy, 2022 to 2032 17.4.1. By Country 17.4.1.1. China 17.4.1.2. Japan 17.4.1.3. South Korea 17.4.2. By Technique 17.4.3. By Application 17.4.4. By End User 17.5. Market Attractiveness Analysis 17.5.1. By Country 17.5.2. By Technique 17.5.3. By Application 17.5.4. By End User 17.6. Market Trends 17.7. Key Market Participants - Intensity Mapping 17.8. Drivers and Restraints - Impact Analysis 17.9. Country-Level Analysis & Forecast 17.9.1. China Market Analysis 17.9.1.1. Introduction 17.9.1.2. Market Analysis and Forecast by Market Taxonomy 17.9.1.2.1. By Technique 17.9.1.2.2. By Application 17.9.1.2.3. By End User 17.9.2. Japan Market Analysis 17.9.2.1. Introduction 17.9.2.2. Market Analysis and Forecast by Market Taxonomy 17.9.2.2.1. By Technique 17.9.2.2.2. By Application 17.9.2.2.3. By End User 17.9.3. South Korea Market Analysis 17.9.3.1. Introduction 17.9.3.2. Market Analysis and Forecast by Market Taxonomy 17.9.3.2.1. By Technique 17.9.3.2.2. By Application 17.9.3.2.3. By Application 17.9.3.2.4. By End User 18. South Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032 18.1. Introduction 18.2. Pricing Analysis 18.3. Historical Market Size (US$ Million) Analysis Trend Analysis By Market Taxonomy, 2017 to 2021 18.4. Market Size (US$ Million) Analysis Forecast By Market Taxonomy, 2022 to 2032 18.4.1. By Country 18.4.1.1. India 18.4.1.2. Indonesia 18.4.1.3. Malaysia 18.4.1.4. Thailand 18.4.1.5. Rest of South Asia 18.4.2. By Technique 18.4.3. By Application 18.4.4. By End User 18.5. Market Attractiveness Analysis 18.5.1. By Country 18.5.2. By Technique 18.5.3. By Application 18.5.4. By End User 18.6. Market Trends 18.7. Key Market Participants - Intensity Mapping 18.8. Drivers and Restraints - Impact Analysis 18.9. Country-Level Analysis & Forecast 18.9.1. India Market Analysis 18.9.1.1. Introduction 18.9.1.2. Market Analysis and Forecast by Market Taxonomy 18.9.1.2.1. By Technique 18.9.1.2.2. By Application 18.9.1.2.3. By End User 18.9.2. Indonesia Market Analysis 18.9.2.1. Introduction 18.9.2.2. Market Analysis and Forecast by Market Taxonomy 18.9.2.2.1. By Technique 18.9.2.2.2. By Application 18.9.2.2.3. By End User 18.9.3. Malaysia Market Analysis 18.9.3.1. Introduction 18.9.3.2. Market Analysis and Forecast by Market Taxonomy 18.9.3.2.1. By Technique 18.9.3.2.2. By Application 18.9.3.2.3. By End User 18.9.4. Thailand Market Analysis 18.9.4.1. Introduction 18.9.4.2. Market Analysis and Forecast by Market Taxonomy 18.9.4.2.1. By Technique 18.9.4.2.2. By Application 18.9.4.2.3. By End User 18.9.5. Rest of South Asia Market Analysis 18.9.5.1. Introduction 18.9.5.2. Market Analysis and Forecast by Market Taxonomy 18.9.5.2.1. By Technique 18.9.5.2.2. By Application 18.9.5.2.3. By End User 19. Oceania Market 2017 to 2021 and Forecast 2022 to 2032 19.1. Introduction 19.2. Pricing Analysis 19.3. Historical Market Size (US$ Million) Analysis Trend Analysis By Market Taxonomy, 2017 to 2021 19.4. Market Size (US$ Million) Analysis Forecast By Market Taxonomy, 2022 to 2032 19.4.1. By Country 19.4.1.1. Australia 19.4.1.2. New Zealand 19.4.2. By Technique 19.4.3. By Application 19.4.4. By End User 19.5. Market Attractiveness Analysis 19.5.1. By Country 19.5.2. By Technique 19.5.3. By Application 19.5.4. By End User 19.6. Key Market Participants - Intensity Mapping 19.7. Drivers and Restraints - Impact Analysis 19.8. Country-Level Analysis & Forecast 19.8.1. Australia Market Analysis 19.8.1.1. Introduction 19.8.1.2. Market Analysis and Forecast by Market Taxonomy 19.8.1.2.1. By Technique 19.8.1.2.2. By Application 19.8.1.2.3. By End User 19.8.2. New Zealand Market Analysis 19.8.2.1. Introduction 19.8.2.2. Market Analysis and Forecast by Market Taxonomy 19.8.2.2.1. By Technique 19.8.2.2.2. By Application 19.8.2.2.3. By End User 20. Middle East and Africa (MEA) Market Analysis 2017 to 2021 and Forecast 2022 to 2032 20.1. Introduction 20.2. Pricing Analysis 20.3. Historical Market Size (US$ Million) Analysis Trend Analysis By Market Taxonomy, 2017 to 2021 20.4. Market Size (US$ Million) Analysis Forecast By Market Taxonomy, 2022 to 2032 20.4.1. By Country 20.4.1.1. GCC Countries 20.4.1.2. Turkey 20.4.1.3. South Africa 20.4.1.4. Rest of Middle East and Africa 20.4.2. By Technique 20.4.3. By Application 20.4.4. By End User 20.5. Market Attractiveness Analysis 20.5.1. By Country 20.5.2. By Technique 20.5.3. By Application 20.5.4. By End User 20.6. Market Trends 20.7. Key Market Participants - Intensity Mapping 20.8. Drivers and Restraints - Impact Analysis 20.9. Country-Level Analysis & Forecast 20.9.1. GCC Countries Market Analysis 20.9.1.1. Introduction 20.9.1.2. Market Analysis and Forecast by Market Taxonomy 20.9.1.2.1. By Technique 20.9.1.2.2. By Application 20.9.1.2.3. By End User 20.9.2. Turkey Market Analysis 20.9.2.1. Introduction 20.9.2.2. Market Analysis and Forecast by Market Taxonomy 20.9.2.2.1. By Technique 20.9.2.2.2. By Application 20.9.2.2.3. By End User 20.9.3. South Africa Market Analysis 20.9.3.1. Introduction 20.9.3.2. Market Analysis and Forecast by Market Taxonomy 20.9.3.2.1. By Technique 20.9.3.2.2. By Application 20.9.3.2.3. By End User 20.9.4. Rest of MEA Market Analysis 20.9.4.1. Introduction 20.9.4.2. Market Analysis and Forecast by Market Taxonomy 20.9.4.2.1. By Technique 20.9.4.2.2. By Application 20.9.4.2.3. By End User 21. Market Structure Analysis 21.1. Market Analysis by Tier of Companies 21.2. Market Share Analysis of Top Players 21.3. Market Presence Analysis 22. Competition Analysis 22.1. Competition Dashboard 22.2. Competition Benchmarking 22.3. Competition Deep Dive 22.3.1. Hologic, Inc. 22.3.1.1. Overview 22.3.1.2. Product Portfolio 22.3.1.3. Profitability by Market Segments (Product/Channel/Region) 22.3.1.4. Sales Footprint 22.3.1.5. Strategy Overview 22.3.2. Becton, Dickinson, and Company 22.3.2.1. Overview 22.3.2.2. Product Portfolio 22.3.2.3. Profitability by Market Segments (Product/Channel/Region) 22.3.2.4. Sales Footprint 22.3.2.5. Strategy Overview 22.3.3. Merit Medical Systems 22.3.3.1. Overview 22.3.3.2. Product Portfolio 22.3.3.3. Profitability by Market Segments (Product/Channel/Region) 22.3.3.4. Sales Footprint 22.3.3.5. Strategy Overview 22.3.4. Laurane Medical LLC 22.3.4.1. Overview 22.3.4.2. Product Portfolio 22.3.4.3. Profitability by Market Segments (Product/Channel/Region) 22.3.4.4. Sales Footprint 22.3.4.5. Strategy Overview 22.3.5. Intramedical Imaging, 22.3.5.1. Overview 22.3.5.2. Product Portfolio 22.3.5.3. Profitability by Market Segments (Product/Channel/Region) 22.3.5.4. Sales Footprint 22.3.5.5. Strategy Overview 22.3.6. Mermaid Medical Group 22.3.6.1. Overview 22.3.6.2. Product Portfolio 22.3.6.3. Profitability by Market Segments (Product/Channel/Region) 22.3.6.4. Sales Footprint 22.3.6.5. Strategy Overview 22.3.7. Izi Medical Products, LLC 22.3.7.1. Overview 22.3.7.2. Product Portfolio 22.3.7.3. Profitability by Market Segments (Product/Channel/Region) 22.3.7.4. Sales Footprint 22.3.7.5. Strategy Overview 22.3.8. MatekMedikal 22.3.8.1. Overview 22.3.8.2. Product Portfolio 22.3.8.3. Profitability by Market Segments (Product/Channel/Region) 22.3.8.4. Sales Footprint 22.3.8.5. Strategy Overview 22.3.9. Tsunami Medical Srl 22.3.9.1. Overview 22.3.9.2. Product Portfolio 22.3.9.3. Profitability by Market Segments (Product/Channel/Region) 22.3.9.4. Sales Footprint 22.3.9.5. Strategy Overview 22.3.10. BPB Medica 22.3.10.1. Overview 22.3.10.2. Product Portfolio 22.3.10.3. Profitability by Market Segments (Product/Channel/Region) 22.3.10.4. Sales Footprint 22.3.10.5. Strategy Overview 22.3.11. Sirius Medical Systems B.V. 22.3.11.1. Overview 22.3.11.2. Product Portfolio 22.3.11.3. Profitability by Market Segments (Product/Channel/Region) 22.3.11.4. Sales Footprint 22.3.11.5. Strategy Overview 22.3.12. Molli Surgical Inc 22.3.12.1. Overview 22.3.12.2. Product Portfolio 22.3.12.3. Profitability by Market Segments (Product/Channel/Region) 22.3.12.4. Sales Footprint 22.3.12.5. Strategy Overview 22.3.13. Sterylab S.R.L. 22.3.13.1. Overview 22.3.13.2. Product Portfolio 22.3.13.3. Profitability by Market Segments (Product/Channel/Region) 22.3.13.4. Sales Footprint 22.3.13.5. Strategy Overview 22.3.14. MDL SRL 22.3.14.1. Overview 22.3.14.2. Product Portfolio 22.3.14.3. Profitability by Market Segments (Product/Channel/Region) 22.3.14.4. Sales Footprint 22.3.14.5. Strategy Overview 22.3.15. Biomedical Srl 22.3.15.1. Overview 22.3.15.2. Product Portfolio 22.3.15.3. Profitability by Market Segments (Product/Channel/Region) 22.3.15.4. Sales Footprint 22.3.15.5. Strategy Overview 22.3.16. Elucent Medical 22.3.16.1. Overview 22.3.16.2. Product Portfolio 22.3.16.3. Profitability by Market Segments (Product/Channel/Region) 22.3.16.4. Sales Footprint 22.3.16.5. Strategy Overview 22.3.17. Vigeosrl 22.3.17.1. Overview 22.3.17.2. Product Portfolio 22.3.17.3. Profitability by Market Segments (Product/Channel/Region) 22.3.17.4. Sales Footprint 22.3.17.5. Strategy Overview 22.3.18. Medax Medical Devices 22.3.18.1. Overview 22.3.18.2. Product Portfolio 22.3.18.3. Profitability by Market Segments (Product/Channel/Region) 22.3.18.4. Sales Footprint 22.3.18.5. Strategy Overview 22.3.19. Isoaid 22.3.19.1. Overview 22.3.19.2. Product Portfolio 22.3.19.3. Profitability by Market Segments (Product/Channel/Region) 22.3.19.4. Sales Footprint 22.3.19.5. Strategy Overview 22.3.20. Tsunami Medical Srl 22.3.20.1. Overview 22.3.20.2. Product Portfolio 22.3.20.3. Profitability by Market Segments (Product/Channel/Region) 22.3.20.4. Sales Footprint 22.3.20.5. Strategy Overview 23. Assumptions and Acronyms Used 24. Research Methodology
Explore Healthcare Insights
View Reports
Breast Lesion Localization Device Market
